Danone and Yakult to accelerate R&D cooperation

By Stephen Daniells

- Last updated on GMT

Related tags: Danone, Groupe danone

France's Danone and Japan's Yakult will continue their strategic
alliance involving closer cooperation on R&D and entry into new
markets, maintaining their positions as leaders in the probiotics
market.

The strengthening of the alliance will see two more Danone executives sitting on the Yakult board, bringing the Danone presence up to four. But Danone will not be increasing its shareholding in Yakult, the two companies confirmed. Danone is already the largest shareholder in Yakult with a 20 per cent stake. Danone's first 5 per cent stake in Yakult, bought in 2000, did little to improve cooperation in the probiotics sector. When Danone upped its stake in Yakult to 20 per cent in April 2003, buying €300 million in shares on the open market, the Japanese firm faced speculation that its shareholder would attempt a hostile takeover bid. Both companies have now announced that Danone will maintain its stake at 20.02 per cent until 2012. "The steady strengthening of this cooperation backed by a permanent liaison bureau had made for a climate of trust that Groupe Danone and Yakult Honsha now wish to reinforce through even closer ties at the highest level of their organisations,"​ stated Danone. The partnership will include the establishment of joint ventures in Vietnam and India, and the founding of a Global Probiotic Council. "Building on these new bases, the partners will be accelerating the pace of co-operation, particularly in research,"​ stated Danone. "In this spirit, Yakult Honsha has just granted Groupe Danone's Daniel Carasso Research Center a license for its YIF-Scan, a unique, high precision system that quantifies bacteria, targeting gene sequences (RNA and DNA) specific to particular intestinal bacteria."​ Sales in probiotics are growing rapidly, as consumers become increasingly aware of the importance of gut health. In Europe, dairy is the biggest area for human food applications. Probiotics are set to reach $137.9 million (€118.5m) in 2010 in Europe, with the US market projected to reach $394 million, according to Frost & Sullivan.

Related news

Show more

Related products

show more

A microbiome solution for every application.

A microbiome solution for every application.

ADM | 07-Dec-2021 | Infographic

Gut health and its impact on overall wellbeing are key drivers for today’s health-conscious consumers. ADM’s microbiome solutions are designed to help...

Expand into new probiotic possibilities

Expand into new probiotic possibilities

Probi AB | 09-Nov-2021 | Application Note

Expand your product range with innovative probiotic solutions in new health areas. Probi ClinBac™, an exclusive range of patented probiotic health concepts,...

OPUNXIA ORGANIC FOR PEOPLE AND PLANET WELLNESS

OPUNXIA ORGANIC FOR PEOPLE AND PLANET WELLNESS

BIONAP Srl | 28-Oct-2021 | Data Sheet

OPUNXIA™ has a high concentrated and standardized polysaccharides profile. It is produced in powder form through specialized technologies to ensure the...

Related suppliers

Follow us

Products

View more

Webinars